Prevalence of Sexual Dysfunction and Effect of Sexologist Support in Women After Rectal Cancer Surgery

What this Trial Is About

This research investigates how common sexual dysfunction is among women after rectal cancer surgery and examines the effects of a sexologists intervention. It focuses on women with stage I-III rectal adenocarcinoma or rectosigmoid junction cancer and aims to improve understanding of sexual health issues in this group, which has been less studied compared to men. The study compares two groups one receiving standard care without sexologist support and another receiving consultations from a sexologist before and after surgery. The sexologist evaluates sexual dysfunction and provides help to improve sexual quality of life if problems are identified. Both groups undergo surgical management with or without preceding radio-chemotherapy. Participants will be assessed before treatment and followed up at 6 and 12 months after surgery. Researchers will measure sexual function using the Female Sexual Function Index FSFI and track changes in sexual satisfaction over time. The study is non-randomized and involves no masking. The total participation duration covers assessments at one month before treatment and at 6 and 12 months post-surgery.

Study of the Prevalence of Sexual Dysfunction in Women After Rectal Cancer Surgery and Analysis of the Impact of a Sexologist Intervention